13 Results for "

IRAK4-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "IRAK4-IN-1" in MCE Product Catalog:

Cat. No.: HY-101922
CAS No.: 1820787-94-7
Purity:  99.88%
Target:  

IRAK

Research Areas:  

Inflammation/Immunology

IRAK4-IN-1 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor with an IC50 of 7 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-129966
CAS No.: 2360533-90-8
Purity:  99.77%
Target:  

PROTACs IRAK

Research Areas:  

Cancer

PROTAC IRAK4 degrader-1 (compound I-210) is a Cereblon-based IRAK4 PROTAC degrader .
loading...
    loading...
Cat. No.: HY-41547
CAS No.: 835616-60-9
Synonyms: Cereblon ligand 4; E3 ligase Ligand 4
Research Areas:  

Cancer

Thalidomide 4-fluoride (Cereblon ligand 4) is the Thalidomide-based Cereblon ligand used in the recruitment of CRBN protein. Thalidomide 4-fluoride (Cereblon ligand 4) can be connected to the ligand for IRAK4 protein by a linker to form PROTAC IRAK4 degrader-1 (HY-129966) .
loading...
    loading...
Cat. No.: HY-W087383
CAS No.: 835616-61-0
Research Areas:  

Cancer

Thalidomide 5-fluoride is a thalidomide-based Cereblon ligand used to recruit Cereblon protein. Thalidomide 5-fluoride can be linked to target protein ligands (e.g. IRAK4) through a linker to form PROTAC molecules (e.g. PROTAC IRAK4 degrader-1). PROTAC IRAK4 degrader-1 caused <20%, >20-50%, and >50% IRAK4 protein degradation in OCI-LY-10 cells at concentrations of 0.01, 0.1, and 1 μM, respectively .
loading...
    loading...
Cat. No.: HY-148238
CAS No.: 2102170-43-2
Target:  

IRAK

Research Areas:  

Inflammation/Immunology

GNE-2256 (molecule 19), a chemical probe, is an orally active IRAK4 (Interleukin 1 receptor associated kinase 4) inhibitor (IRAK4 Ki=1.4 nM; IL-6 IC50=190 nM) .
loading...
    loading...
Cat. No.: HY-129967
CAS No.: 2357108-39-3
Purity:  99.49%
Research Areas:  

Cancer

PROTAC IRAK4 ligand-1 is a synthetic ligand for interleukin-1 receptor-associated kinase 4 (IRAK4). PROTAC IRAK4 ligand-1 can be used in the synthesis of PROTAC IRAK4 degrader-1 (HY-129966) .
loading...
    loading...
Cat. No.: HY-101922R
CAS No.: 1820787-94-7
Research Areas:  

Inflammation/Immunology

IRAK4-IN-1 (Standard) is the analytical standard of IRAK4-IN-1 (HY-101922). This product is intended for research and analytical applications. IRAK4-IN-1 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor with an IC50 of 7 nM.
loading...
    loading...
Cat. No.: HY-176735
Target:  

IRAK FLT3 Apoptosis

Research Areas:  

Cancer

FLT3/IRAK4-IN-1 is a selective FLT3/IRAK4 inhibitor with the remarkable activity towards FLT3-WT (IC50 = 1.95 nM), FLT3-D835Y (IC50 = 3.22 nM) and IRAK4 (IC50 = 53.72 nM). LT3/IRAK4-IN-1 has relatively low toxicity to normal bone marrow cells, can effectively promote cell apoptosis, and has the potential to overcome drug resistance. FLT3/IRAK4-IN-1 can be used for research on acute myeloid leukemia (AML) .
loading...
    loading...
Cat. No.: HY-160654
CAS No.: 1356014-97-5
Target:  

IRAK

Research Areas:  

Inflammation/Immunology

IRAK4 modulator-1 (example 161) is a modulator of IRAK4 with IC50=4.647 μM. IRAK4 modulator-1 can be used to study IRAK-mediated disorders .
loading...
    loading...
Cat. No.: HY-143231
CAS No.: 2033070-97-0
Target:  

IRAK

Research Areas:  

Infection

IRAK4-IN-8 (VI-177) is a potent IRAK4 inhibitor .
loading...
    loading...
Cat. No.: HY-129968
CAS No.: 2357108-99-5
Purity:  98.22%
Target:  

PROTAC Linkers

Research Areas:  

Cancer

AM-Imidazole-PA-Boc is an alkyl chain-based PROTAC linker can be used in the synthesis of PROTAC IRAK4 degrader-1 (HY-129966) .
loading...
    loading...
Cat. No.: HY-150593
CAS No.: 1812188-83-2
Target:  

IRAK

Research Areas:  

Cancer

IRAK4-IN-16 (compound 4) is a potent IRAK4 (interleukin-1 receptor associated kinase 4) inhibitor, with an IC50 of 2.5 nM. IRAK4-IN-16 shows cytotoxicity activity against OCI-LY10, TMD8, Ramos and HT cells, with IC50 values of 0.2, 0.2, 0.6, and 2.7 μM, respectively .
loading...
    loading...
Cat. No.: HY-168586
CAS No.: 2919995-09-6
Target:  

PROTACs IRAK IKZF Family

Research Areas:  

Cancer

PROTAC IRAK4 degrader-12 is an orally active IRAK4 PROTAC degrader with a DC50 of 4.87 nM in K562 IRAK4-HiBiT cells. PROTAC IRAK4 degrader-12 induces protein degradation of IRAK4, IKZF1 and IKZF3. It inhibits the proliferation of diffuse large B-cell lymphoma cells. It suppresses tumor growth in mouse xenograft models of lymphoma cells. PROTAC IRAK4 degrader-12 can be used for the research of B-cell lymphoma and diffuse large B-cell lymphoma .
loading...
    loading...
  • 1